Healthcare / Medical Care FacilitiesJakarta
$184.00
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 19%
FCF escenarios
weak_data · normalized FCF $-157.9B · quality 51.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
30/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.58T
P/E
176.9x
↑EV/EBITDA
10.9x
↓ROE
0.6%
↑Gross Margin
46.1%
↓Debt/Equity
0.70
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-0.9%
FCF CAGR
—
FCF margin
2.0%
FCF / Net income
2.55x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.61T · net income $12.42B · FCF $31.72B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1614.34B | $1614.34B | $1554.69B | $1488.20B | $1658.69B |
| Net Income | $12.42B | $12.42B | $11.94B | $7.46B | $83.23B |
| EBITDA | $228.55B | $228.55B | $212.48B | $203.45B | $323.29B |
| EPS | 1.40 | 1.40 | 1.40 | 0.90 | 9.70 |
| Gross Margin | 46.1% | 46.1% | 45.5% | 46.8% | 46.1% |
| Operating Margin | 5.8% | 5.8% | 5.7% | 5.9% | 13.0% |
| Net Margin | 0.8% | 0.8% | 0.8% | 0.5% | 5.0% |
| Balance Sheet | |||||
| Debt/Equity | 0.70 | 0.70 | 0.68 | 0.70 | 0.58 |
| Current Ratio | 1.62 | 1.62 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $31.72B | $31.72B | $-202.05B | $-157.91B | $-170.65B |
| Returns | |||||
| ROE | 0.6% | 0.6% | 0.7% | 0.5% | 5.2% |
| Valuation | |||||
| P/E | 176.92 | 176.92 | 185.71 | 353.33 | 43.30 |
| EV/EBITDA | 10.89 | 10.89 | 13.22 | 18.11 | 12.23 |
| P/B | 0.70 | 0.70 | 1.13 | 1.72 | 2.26 |
| Growth & Yield | |||||
| Revenue Growth | 3.8% | 3.8% | 4.5% | -10.3% | — |
| EPS Growth | 0.0% | 0.0% | 55.6% | -90.7% | — |
| Dividend Yield | 0.3% | 0.3% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
126.8%
EPS terminal req.
$16.33
Spread vs growth
-126.8%
5Y implied EPS CAGR
69.8%
EPS terminal req.
$19.76
Spread vs growth
-69.8%
10Y implied EPS CAGR
36.7%
EPS terminal req.
$31.82
Spread vs growth
-36.7%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-22.6%
Start / end P/E
171.4x → 132.1x
EPS bridge
1.40 → 1.40
Residual
+0.0%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.